Skip to main content

Cancer Trials and the Institutional Review Board (IRB)

  • Chapter
Cancer Clinical Trials: Proactive Strategies

Part of the book series: Cancer Treatment and Research ((CTAR,volume 132))

  • 864 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Simes, R.J. and A.S. Coates, Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? Journal of the National Cancer Institute. Monographs, 2001(30): p. 146–52.

    PubMed  Google Scholar 

  2. Beecher, H., Ethics and Clinical Research. N Engl J Med, 1966. 274: p. 1354–1360.

    Article  PubMed  CAS  Google Scholar 

  3. Lazzarini, Z. and F.L. Altice, A review of the legal and ethical issues for the conduct of HIV-related research in prisons. AIDS & Public Policy Journal, 2000. 15(3–4): p. 105–35.

    CAS  Google Scholar 

  4. Survey-Use of Prisoners in Drug testing, in Report to the National Commission. 1976, Pharmaceutical Manufacturers Association.

    Google Scholar 

  5. Prison Drug Test: Choice or Coercion, in Los Angeles Times. 1981: Los Angeles. p. 27.

    Google Scholar 

  6. in Code of Federal Regulations. 2001.

    Google Scholar 

  7. Steinbrook, R., Testing medications in children. [see comment]. New England Journal of Medicine, 2002. 347(18): p. 1462–70.

    Article  PubMed  Google Scholar 

  8. Gurwitz, J.H., Testing medications in children. [comment]. New England Journal of Medicine, 2003. 348(8): p. 763–4; author reply 763–4.

    Article  PubMed  Google Scholar 

  9. Crawley, F.P., R. Kurz, and H. Nakamura, Testing medications in children. [comment]. New England Journal of Medicine, 2003. 348(8): p. 763–4; author reply 763–4.

    Article  PubMed  Google Scholar 

  10. Shakespeare, W, Julius Caesar. Act 3, scene 2.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kurtzman, S., Lazzarini, Z. (2007). Cancer Trials and the Institutional Review Board (IRB). In: Leong, S.P.L. (eds) Cancer Clinical Trials: Proactive Strategies. Cancer Treatment and Research, vol 132. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-33225-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-33225-3_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-33224-6

  • Online ISBN: 978-0-387-33225-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics